ArticleCellular and molecular life sciences : CMLS2025
γ9δ2 T cells detect mevalonate diphosphate via BTN3A3.
Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- NanoBRET Saturation Analysis with a Novel HaloTag Ligand Reveals Butyrophilin Heteromeric Interactions Controlling γ9δ2 T Cell Activation.ACS chemical biology · 2026Article
- Cell stress activates γ9δ2 T cells via endogenous phosphoantigens and butyrophilin complex dynamics.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Butyrophilins (BTNs) act as critical sensors of phosphoantigens (pAgs), mediating the immune response to these small molecules. The natural ligands for BTN3A1 include the exogenous (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) and endogenous pAgs dimethyl allyl diphosphate (DMAPP) and isopentenyl diphosphate (IPP), all of which can bind to BTN3A1 followed by activation of γ9δ2 T cells. BTN3A1 shares similar structural domains and exhibits high amino acid sequence homology with BTN3A3. However, the potential functions of BTN3A3 and whether it possesses ligands of its own remain unknown. Here, we show that a single point mutation to BTN3A3 allows it to detect HMBPP, suggesting that the protein may have its own ligand. Mevalonate diphosphate (MPP), a naturally occurring endogenous compound, exhibits high docking scores with both BTN3A1 and BTN3A3. Functional testing revealed that MPP activates γ9δ2 T cells, albeit with a higher EC
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.